You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

What Factors Affect Childhood Cancer Survivorship?

  • Authors: News Author: Megan Brooks; CME Author: Laurie Barclay, MD
  • CME / ABIM MOC / CE Released: 3/31/2023
  • Valid for credit through: 3/31/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for hematologists/oncologists, pediatricians, family medicine/primary care clinicians, internists, pharmacists, nurses, physician assistants, and other members of the health care team for children with cancer.

The goal of this activity is for learners to be better able to describe associations between modifiable chronic health conditions and late mortality (death occurring ≥5 years after cancer diagnosis) in childhood cancer survivors within the context of social determinants of health.

Upon completion of this activity, participants will:

  • Determine the associations between modifiable chronic health conditions and late mortality in childhood cancer survivors within the context of social determinants of health
  • Evaluate the clinical and public health implications of associations between modifiable chronic health conditions and late mortality in childhood cancer survivors within the context of social determinants of health
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Megan Brooks

    Freelance writer, Medscape

    Disclosures

    Megan Brooks, has no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Laurie Barclay, MD, has no relevant financial relationships.

Editor/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-094-H01-P).

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 03/31/2023. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

What Factors Affect Childhood Cancer Survivorship?

Authors: News Author: Megan Brooks; CME Author: Laurie Barclay, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 3/31/2023

Valid for credit through: 3/31/2024, 11:59 PM EST

processing....

Clinical Context

The increasing population of long-term cancer survivors remains at high risk for premature death, despite reduced treatment intensity, mostly from subsequent cancers and cardiac and pulmonary causes. Modifiable cardiovascular and other risk factors suggest potential interventions to reduce late mortality.

Behavioral and lifestyle factors, including physical activity and tobacco use, may also affect late mortality. Childhood cancer survivors commonly experience individual-level disadvantages, including lower educational attainment, unemployment, inadequate insurance, and lower income, which may all lower health care access and survival.

Study Synopsis and Perspective

Modifiable chronic health conditions and socioeconomic factors may raise the risk for death in adult survivors of childhood cancer, according to new data from the St Jude Lifetime Cohort.

Survivors with a greater number and severity of modifiable chronic health conditions, as well as those living in the most vs least resource-deprived areas, had a significantly higher risk for all-cause and health-related late death.

Finding ways to mitigate these factors “will be important to improving health outcomes and developing risk-stratification strategies to optimize care delivery to survivors at varying risk of adverse health events,” the researchers write.

The study indicates that treating chronic health conditions alone may not be enough to increase a cancer survivor’s lifespan; improving local environments matters too.

“It is important for clinicians to ask patients about their specific situation,” first author Matthew J. Ehrhardt, MD, Department of Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee, said in a news release. “It’s easy to prescribe medications or to tell people to exercise. It takes more time and more thoughtfulness to sit and understand environments in which they are residing.”

“As clinicians, we may have limited ability to modify some of those factors. But we can work closely with the rest of the healthcare team, such as social workers, for example, to help survivors to identify and access local resources,” Dr Ehrhardt added.

The study was published online February 10 in JAMA Network Open.[1]

A growing population of childhood cancer survivors faces an increased risk for premature death in the years after their diagnosis. However, associations among social determinants of health, modifiable health conditions, and late mortality in childhood cancer survivors remain unclear.

To assess late mortality, the study team analyzed data on 9440 participants (median age at assessment, 27.5 years; range, 5.3 to 71.9 years) who lived at least 5 years after being diagnosed with a childhood cancer between 1962 and 2012.

During a median follow-up of about 18 years, childhood cancer survivors had an increased rate for both all-cause and health-related late mortality (standardized mortality rate [SMR], 7.6 for both). Among specific health-related causes of death, SMRs were 16.0 for subsequent neoplasms, 9.0 for pulmonary causes, 4.2 for cardiac causes, and 4.3 for other health-related causes.

To evaluate ties among modifiable chronic health conditions, social determinants, and late mortality, the researchers restricted their analysis to 3407 adult study participants for whom relevant data were available. Modifiable chronic health conditions included dyslipidemia, hypertension, diabetes, underweight or obesity, bone mineral deficiency, and hypothyroidism.

After adjusting for individual factors, including age at diagnosis and treatment, as well as neighborhood-level factors, the researchers observed a significantly increased risk for death among survivors with 1 or more modifiable chronic health conditions of grade 2 or higher (relative risk [RR], 2.2), 2 chronic health conditions of grade 2 or higher (RR, 2.6) or 3 chronic health conditions of grade 2 or higher (RR, 3.6).

These findings suggest that “increased late mortality experienced by childhood cancer survivors in adulthood may not be predetermined by treatment-related risk factors alone,” the researchers say.

In addition, survivors living in the most disadvantaged areas, as measured by the area deprivation index (ADI), had a 5- to 8-fold increased risk for late death from any cause compared with those living in the least disadvantaged areas, even after adjusting for modifiable chronic health conditions, cancer treatment, demographics, and individual socioeconomic factors.

The findings have important public health implications, Ehrhardt and colleagues said. The results can, for instance, help identify and stratify cancer survivors at higher lifetime risk for specific chronic conditions and late death. 

This risk-stratified approach to care, however, is “relatively static” and does not account for risk factors acquired after cancer diagnosis and treatment, such as social determinants of health.

That is why also focusing on socioeconomic factors is important, and transitional care services after cancer treatment should consider that survivors in disadvantaged neighborhoods may lack supportive resources to address health issues, potentially leading to increased risk for death, the researchers said.

The knowledge that living in a resource-poor neighborhood may raise the risk for late death in childhood cancer survivors “strengthens support for public health policies that will direct resources to such regions and facilitate a multipronged approach to risk mitigation,” the authors conclude.

This study was supported by grants from the National Institutes of Health (NIH) and the American Lebanese Syrian Associated Charities. The authors have disclosed no relevant financial relationships.

JAMA Netw Open. Published online February 10, 2023.

Study Highlights

  • This longitudinal cohort study used data from 9440 SJLIFE participants (median age at assessment, 27.5 [range, 5.3-71.9] years; median follow-up duration, 18.8 [range, 5.0-58.0] years; 55.2% were male; 75.3% were non-Hispanic White).
  • Participants eligible for risk factor analyses (n=3407) were aged at least 18 years, survived at least 5 years after childhood cancer diagnosis, were diagnosed between 1962 and 2012, and received treatment at St Jude Children’s Research Hospital.
  • Their age at assessment was 35.4 (95% CI, 17.9-69.8) years, duration of follow-up was 27.3 (95% CI, 7.3-54.7) years, 52.5% were male, and 81.7% were non-Hispanic White.
  • The National Death Index allowed determination of vital status and date/cause of death.
  • Deaths occurring before National Death Index inception were obtained from St Jude Children’s Research Hospital Cancer Registry.
  • SMRs were calculated on the basis of US mortality rates.
  • Modifiable chronic health conditions (CHCs) were dyslipidemia, hypertension, diabetes, underweight or obesity, bone mineral deficiency, hypogonadism, hypothyroidism, and adrenal insufficiency.
  • Frailty included low lean muscle mass, exhaustion, low energy expenditure, slowness, and weakness.
  • ADI measured neighborhood-level socioeconomic disadvantage.
  • Risk factor analyses used multivariable piecewise exponential regression analysis to estimate RRs for all-cause and cause-specific late mortality.
  • Childhood cancer survivors (n=9440) had increases in all-cause mortality (SMR, 7.6; 95% CI, 7.2-8.1), health-related late mortality (SMR, 7.6; 95% CI, 7.0-8.2), and death from subsequent neoplasms (RR, 16.0), pulmonary causes (RR, 9.0), cardiac causes (RR, 4.2), and other health-related causes (RR, 4.3).
  • In models adjusted for attained age, sex, race and ethnicity, age at diagnosis, treatment exposures, household income, employment, and insurance, various factors were associated with significantly increased risk for late all-cause death.
  • These were modifiable CHC grade at least 2 (RR, 2.2 [95% CI, 1.2-4.0; P=.01] for 1; RR, 2.6 [95% CI, 1.4-4.9; P=.003] for 2; and RR, 3.6 [95% CI, 1.8-7.1; P<.001] for 3 CHCs); area deprivation index (ADI; 51st-80th percentile: RR, 5.5 [95% CI, 1.3-23.5, P=.02]; 81st-100th percentile: 8.7 [95% CI, 2.0-37.6; P=.004]; unassigned: RR, 15.7 [95% CI, 3.5-70.3; P<.001]); and frailty (RR, 2.3; 95% CI, 1.3-3.9; P=.004).
  • Associations were similar for risk for late health-related death.
  • The investigators concluded that childhood cancer survivors had 7-fold significantly increased risk for all-cause and health-related death, after adjustment for personal demographic, treatment, and socioeconomic factors.
  • Participants having at least 10 CHCs of grade 1 to 4 or at least 3 CHCs of grade 3 to 4 at baseline had highest risk for death (as early as 2 years after baseline assessment).
  • Having at least 1 modifiable CHC of grade at least 2 or higher, living in a US census block with the most disadvantaged ADI (5- to 8-fold increased risk), and frailty were independently associated with significant increases in all-cause and health-related late mortality.
  • This suggests that treatment-related risk factors alone may not predetermine increased late mortality.
  • Future research aiming to mitigate risk factors is needed to improve health outcomes and develop risk-stratification strategies to optimize care delivery to childhood cancer survivors.
  • Studies of risk factors should design interventions deliverable within the constructs of available resources.
  • Health policies to remove barriers inherent to disadvantaged regions are needed to lower mortality risk for this population of patients with medically complex conditions.
  • Treating CHCs alone without improving local environments may be insufficient to increase survival.
  • Survivors in disadvantaged neighborhoods may lack supportive resources to address health issues via transitional care services, potentially increasing mortality risk.
  • Use of the ADI might identify patients, using physical address alone, who are returning to the most challenging socioeconomic environments and may benefit from aggressive transitional care services.
  • Clinicians should ask patients about their CHCs and specific socioeconomic situation and collaborate with social workers and other multidisciplinary healthcare team members to help survivors identify and access local resources.
  • Public health implications of the findings include helping identify and stratify cancer survivors at higher lifetime risk for specific CHCs and late death.
  • However, a risk-stratified approach to care is relatively static, not accounting for social determinants of health and other risk factors developing after cancer diagnosis and treatment.
  • Increased late mortality risks in childhood cancer survivors living in a disadvantaged neighborhood supports public health policies directing resources to such regions and facilitates a multipronged strategy for risk mitigation, including addressing food deserts and lack of green spaces.

Clinical Implications

  • Childhood cancer survivors had 7-fold significantly increased adjusted risk for all-cause and health-related death.
  • Treatment-related risk factors alone may not predetermine increased late mortality.
  • Implications for the Health Care Team: Clinicians should ask patients about their CHCs and specific socioeconomic situation and collaborate with social workers and other healthcare team members to help survivors identify and access local resources.

 

Earn Credit

  • Print